The medical community is abuzz with anticipation surrounding retatrutide, a new dual GIP and GLP-1 target that’s demonstrating significant efficacy in clinical trials for managing obesity. Unlike some existing weight loss solutions, retatrutide appears to offer a significant substantial decrease in body size and benefit metabolic health, particul